BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27807175)

  • 1. Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.
    Sidoli M; Musner N; Silvestri N; Ungaro D; D'Antonio M; Cavener DR; Feltri ML; Wrabetz L
    J Neurosci; 2016 Nov; 36(44):11350-11361. PubMed ID: 27807175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR.
    Scapin C; Ferri C; Pettinato E; Bianchi F; Del Carro U; Feltri ML; Kaufman RJ; Wrabetz L; D'Antonio M
    J Neurosci; 2020 Oct; 40(42):8174-8187. PubMed ID: 32973043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
    Musner N; Sidoli M; Zambroni D; Del Carro U; Ungaro D; D'Antonio M; Feltri ML; Wrabetz L
    ASN Neuro; 2016; 8(2):. PubMed ID: 27095827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin Activity Is Increased in Charcot-Marie-Tooth 1B Demyelinating Neuropathy.
    Sidoli M; Reed CB; Scapin C; Paez P; Cavener DR; Kaufman RJ; D'Antonio M; Feltri ML; Wrabetz L
    J Neurosci; 2021 May; 41(20):4536-4548. PubMed ID: 33879538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model.
    Florio F; Ferri C; Scapin C; Feltri ML; Wrabetz L; D'Antonio M
    J Neurosci; 2018 May; 38(18):4275-4287. PubMed ID: 29610440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice.
    Volpi VG; Ferri C; Fregno I; Del Carro U; Bianchi F; Scapin C; Pettinato E; Solda T; Feltri ML; Molinari M; Wrabetz L; D'Antonio M
    PLoS Genet; 2019 Apr; 15(4):e1008069. PubMed ID: 30995221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice.
    D'Antonio M; Musner N; Scapin C; Ungaro D; Del Carro U; Ron D; Feltri ML; Wrabetz L
    J Exp Med; 2013 Apr; 210(4):821-38. PubMed ID: 23547100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
    Bai Y; Treins C; Volpi VG; Scapin C; Ferri C; Mastrangelo R; Touvier T; Florio F; Bianchi F; Del Carro U; Baas FF; Wang D; Miniou P; Guedat P; Shy ME; D'Antonio M
    Mol Neurobiol; 2022 Jul; 59(7):4159-4178. PubMed ID: 35501630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.
    Touvier T; Veneri FA; Claessens A; Ferri C; Mastrangelo R; Sorgiati N; Bianchi F; Valenzano S; Del Carro U; Rivellini C; Duong P; Shy ME; Kelly JW; Svaren J; Wiseman RL; D'Antonio M
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
    Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME
    Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.
    Pennuto M; Tinelli E; Malaguti M; Del Carro U; D'Antonio M; Ron D; Quattrini A; Feltri ML; Wrabetz L
    Neuron; 2008 Feb; 57(3):393-405. PubMed ID: 18255032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.
    Patzkó A; Bai Y; Saporta MA; Katona I; Wu X; Vizzuso D; Feltri ML; Wang S; Dillon LM; Kamholz J; Kirschner D; Sarkar FH; Wrabetz L; Shy ME
    Brain; 2012 Dec; 135(Pt 12):3551-66. PubMed ID: 23250879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
    J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
    Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
    J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
    Vijay S; Chiu M; Dacks JB; Roberts RC
    Biochim Biophys Acta; 2016 Jul; 1862(7):1279-90. PubMed ID: 27068304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy.
    VerPlank JJS; Gawron J; Silvestri NJ; Feltri ML; Wrabetz L; Goldberg AL
    Brain; 2022 Mar; 145(1):168-178. PubMed ID: 34382059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
    Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
    Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
    Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells.
    Chojnowski A; Ravisé N; Bachelin C; Depienne C; Ruberg M; Brugg B; Laporte J; Baron-Van Evercooren A; LeGuern E
    Neurobiol Dis; 2007 May; 26(2):323-31. PubMed ID: 17336078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.